M. Schütt

1.1k total citations
40 papers, 747 citations indexed

About

M. Schütt is a scholar working on Endocrinology, Diabetes and Metabolism, Infectious Diseases and Surgery. According to data from OpenAlex, M. Schütt has authored 40 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Infectious Diseases and 7 papers in Surgery. Recurrent topics in M. Schütt's work include Diabetes Management and Research (7 papers), Viral Infections and Vectors (6 papers) and Diabetes Treatment and Management (6 papers). M. Schütt is often cited by papers focused on Diabetes Management and Research (7 papers), Viral Infections and Vectors (6 papers) and Diabetes Treatment and Management (6 papers). M. Schütt collaborates with scholars based in Germany, Austria and Slovakia. M. Schütt's co-authors include Reinhard W. Holl, W. Kerner, Christian von Wagner, H Meisel, Rainer G. Ulrich, W. Kern, Joachim Rosenbauer, Ulf von Krause, Petra Busch and Anca Zimmermann and has published in prestigious journals such as European Heart Journal, Diabetologia and International Journal of Obesity.

In The Last Decade

M. Schütt

37 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Schütt Germany 16 327 206 136 127 100 40 747
Maya Gopalakrishnan India 9 45 0.1× 64 0.3× 118 0.9× 7 0.1× 20 0.2× 43 326
Subramanian Senthilkumaran India 13 24 0.1× 21 0.1× 198 1.5× 9 0.1× 72 0.7× 109 651
Dragan Dekaris Croatia 14 34 0.1× 147 0.7× 18 0.1× 82 0.6× 22 0.2× 54 712
Giulia Brigante Italy 16 362 1.1× 66 0.3× 143 1.1× 1 0.0× 63 0.6× 58 924
Sarah Wilson United Kingdom 12 29 0.1× 80 0.4× 51 0.4× 4 0.0× 57 0.6× 31 535
Vanessa S. Mattevi Brazil 18 98 0.3× 77 0.4× 174 1.3× 56 0.6× 47 832
Wendell H. Niemann United States 19 65 0.2× 52 0.3× 87 0.6× 2 0.0× 105 1.1× 44 900
Ozgul Muneyyirci‐Delale United States 18 190 0.6× 58 0.3× 75 0.6× 63 0.6× 60 998
D. Jaquet France 23 306 0.9× 108 0.5× 117 0.9× 79 0.8× 34 2.0k
R Deutsch United States 7 122 0.4× 161 0.8× 26 0.2× 66 0.7× 9 537

Countries citing papers authored by M. Schütt

Since Specialization
Citations

This map shows the geographic impact of M. Schütt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Schütt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Schütt more than expected).

Fields of papers citing papers by M. Schütt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Schütt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Schütt. The network helps show where M. Schütt may publish in the future.

Co-authorship network of co-authors of M. Schütt

This figure shows the co-authorship network connecting the top 25 collaborators of M. Schütt. A scholar is included among the top collaborators of M. Schütt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Schütt. M. Schütt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Witt, Olaf, et al.. (2025). Long-Term Real-World Data from glucura: A Digital Therapeutic (DiGA) for Personalized Lifestyle Therapy for Type 2 Diabetes.. Diabetologie und Stoffwechsel. 20. 1 indexed citations
3.
Johannsen, Jessika, Deike Weiss, M. Schütt, et al.. (2023). High-sensitive cardiac troponin I (hs-cTnI) concentrations in newborns diagnosed with spinal muscular atrophy. Frontiers in Pediatrics. 11. 3 indexed citations
4.
Krakow, D, A Voll, Andrej Zeyfang, et al.. (2012). Type 2 diabetes from pediatric to geriatric age: analysis of gender and obesity among 120 183 patients from the German/Austrian DPV database. European Journal of Endocrinology. 167(2). 245–254. 62 indexed citations
5.
Schütt, M., et al.. (2012). Endokrine Notfälle in der Schwangerschaft. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 107(2). 110–7.
6.
Üçeyler, Nurcan, M. Schütt, Carola Vogel, et al.. (2010). Lack of the serotonin transporter in mice reduces locomotor activity and leads to gender-dependent late onset obesity. International Journal of Obesity. 34(4). 701–711. 38 indexed citations
7.
Schütt, M., Wolfgang Kern, Anca Zimmermann, et al.. (2010). Association of Antidiabetic Therapies to Glycemic Control and to Body Weight in Type 2 Diabetes: A German Multicenter Analysis on 9.294 Patients. Experimental and Clinical Endocrinology & Diabetes. 118(8). 490–495. 3 indexed citations
8.
Dodt, Christoph, et al.. (2008). Glukokortikoide und Hypertonie. Der Internist. 50(1). 36–41. 5 indexed citations
9.
Meier, Matthias, Udo Helmchen, Lutz Fricke, Reiner Ulrich, & M. Schütt. (2007). Acute hantavirus infection or renal transplant rejection. Transplant Infectious Disease. 9(3). 225–228. 4 indexed citations
10.
Schütt, M., W. Kern, Ulf von Krause, et al.. (2006). Is the Frequency of Self-Monitoring of Blood Glucose Related to Long-Term Metabolic Control? Multicenter Analysis Including 24 500 Patients from 191 Centers in Germany and Austria. Experimental and Clinical Endocrinology & Diabetes. 114(7). 384–388. 166 indexed citations
11.
Meisel, H, M. Schütt, Jonas Schmidt, et al.. (2004). Verbreitung von Hantavirusinfektionen in Deutschland. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 47(7). 661–670. 25 indexed citations
12.
Schütt, M., Markus K Meier, Marco Jost, & H. H. Klein. (2003). The HIV Protease Inhibitor Indinavir Impairs Glycogen Synthesis in HepG2 Hepatoma Cells. Experimental and Clinical Endocrinology & Diabetes. 111(1). 16–20. 8 indexed citations
13.
Seidel, Bastian, Annegret Glasow, M. Schütt, et al.. (2003). Association between the GH receptor/exon 3 genotype and the level of exon 3-positive GH-binding protein in human serum. European Journal of Endocrinology. 148(3). 317–324. 14 indexed citations
14.
15.
Schütt, M., et al.. (2000). Functional characteristics of insulin receptors with a Thr-->Ser1200 mutation overexpressed in Chinese hamster ovary cells. European Journal of Endocrinology. 143(1). 125–131. 1 indexed citations
16.
Schütt, M., et al.. (2000). The HIV-1 protease inhibitor indinavir impairs insulin signalling in HepG2 hepatoma cells. Diabetologia. 43(9). 1145–1148. 40 indexed citations
17.
Schütt, M., Harald Klüter, G. Wiedemann, & Gert Richardt. (2000). Coexistence of factor V Leiden and primary antiphospholipid syndrome: a patient with recurrent myocardial infarctions and thrombocytopenia. Zeitschrift für Kardiologie. 89(12). 1067–1071. 5 indexed citations
18.
Schütt, M., et al.. (1995). Über die Fettkristallisation im emulgierten Zustand unter hohem hydrostatischen Druck. 47(3). 209–220. 2 indexed citations
20.
Küpper, W., M. Schütt, & W. Bleifeld. (1982). Effect of intravenous prenalterol on haemodynamics and myocardial lactate extraction in patients with left ventricular failure. Acta Medica Scandinavica. 211(S659). 287–298. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026